Last updated on November 2018

A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurrent Ovarian Cancer


Brief description of study

The purpose of this study is to evaluate the efficacy and safety of prexasertib in women with platinum-resistant or refractory recurrent ovarian cancer.

Clinical Study Identifier: NCT03414047

Contact Investigators or Research Sites near you

Start Over

MICHAEL A. GOLD

Cancer Care Associates
Tulsa, OK United States
3.3miles
  Connect »